Cargando…

Plantar threshold sensitivity assessment using an automated tool—Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms

Diabetic peripheral neuropathy is often classified as a loss of sensation in the extremities, particularly in elderly populations. The most common diagnosis technique is with the use of the hand-applied Semmes-Weinstein monofilament. This study’s first aim was to quantify and compare sensation on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellano, Vitale Kyle, Commander, Jon, Burch, Thomas, Burch, Hayden, Remy, Jessica, Harman, Benjamin, Zabala, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328367/
https://www.ncbi.nlm.nih.gov/pubmed/37418442
http://dx.doi.org/10.1371/journal.pone.0286559
_version_ 1785069783368073216
author Castellano, Vitale Kyle
Commander, Jon
Burch, Thomas
Burch, Hayden
Remy, Jessica
Harman, Benjamin
Zabala, Michael E.
author_facet Castellano, Vitale Kyle
Commander, Jon
Burch, Thomas
Burch, Hayden
Remy, Jessica
Harman, Benjamin
Zabala, Michael E.
author_sort Castellano, Vitale Kyle
collection PubMed
description Diabetic peripheral neuropathy is often classified as a loss of sensation in the extremities, particularly in elderly populations. The most common diagnosis technique is with the use of the hand-applied Semmes-Weinstein monofilament. This study’s first aim was to quantify and compare sensation on the plantar surface in healthy and type 2 diabetes mellitus populations with the standard Semmes-Weinstein hand-applied methodology and a tool that automates this approach. The second was to evaluate correlations between sensation and the subjects’ medical characteristics. Sensation was quantified by both tools, at thirteen locations per foot, in three populations: Group 1-control subjects without type 2 diabetes, Group 2-subjects with type 2 diabetes and with neuropathy symptoms, and Group 3-subjects with type 2 diabetes without neuropathy symptoms. The percentage of locations sensitive to the hand-applied monofilament, yet insensitive to the automated tool was calculated. Linear regression analyses between sensation and the subject’s age, body mass index, ankle brachial index, and hyperglycemia metrics were performed per group. ANOVAs determined differences between populations. Approximately 22.5% of locations assessed were sensitive to the hand-applied monofilament, yet insensitive to the automated tool. Age and sensation were only significantly correlated in Group 1 (R(2) = 0.3422, P = 0.004). Sensation was not significantly correlated with the other medical characteristics per group. Differences in sensation between the groups were not significant (P = 0.063). Caution is recommended when using hand-applied monofilaments. Group 1’s sensation was correlated to age. The other medical characteristics failed to corelate with sensation, despite group.
format Online
Article
Text
id pubmed-10328367
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-103283672023-07-08 Plantar threshold sensitivity assessment using an automated tool—Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms Castellano, Vitale Kyle Commander, Jon Burch, Thomas Burch, Hayden Remy, Jessica Harman, Benjamin Zabala, Michael E. PLoS One Research Article Diabetic peripheral neuropathy is often classified as a loss of sensation in the extremities, particularly in elderly populations. The most common diagnosis technique is with the use of the hand-applied Semmes-Weinstein monofilament. This study’s first aim was to quantify and compare sensation on the plantar surface in healthy and type 2 diabetes mellitus populations with the standard Semmes-Weinstein hand-applied methodology and a tool that automates this approach. The second was to evaluate correlations between sensation and the subjects’ medical characteristics. Sensation was quantified by both tools, at thirteen locations per foot, in three populations: Group 1-control subjects without type 2 diabetes, Group 2-subjects with type 2 diabetes and with neuropathy symptoms, and Group 3-subjects with type 2 diabetes without neuropathy symptoms. The percentage of locations sensitive to the hand-applied monofilament, yet insensitive to the automated tool was calculated. Linear regression analyses between sensation and the subject’s age, body mass index, ankle brachial index, and hyperglycemia metrics were performed per group. ANOVAs determined differences between populations. Approximately 22.5% of locations assessed were sensitive to the hand-applied monofilament, yet insensitive to the automated tool. Age and sensation were only significantly correlated in Group 1 (R(2) = 0.3422, P = 0.004). Sensation was not significantly correlated with the other medical characteristics per group. Differences in sensation between the groups were not significant (P = 0.063). Caution is recommended when using hand-applied monofilaments. Group 1’s sensation was correlated to age. The other medical characteristics failed to corelate with sensation, despite group. Public Library of Science 2023-07-07 /pmc/articles/PMC10328367/ /pubmed/37418442 http://dx.doi.org/10.1371/journal.pone.0286559 Text en © 2023 Castellano et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Castellano, Vitale Kyle
Commander, Jon
Burch, Thomas
Burch, Hayden
Remy, Jessica
Harman, Benjamin
Zabala, Michael E.
Plantar threshold sensitivity assessment using an automated tool—Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms
title Plantar threshold sensitivity assessment using an automated tool—Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms
title_full Plantar threshold sensitivity assessment using an automated tool—Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms
title_fullStr Plantar threshold sensitivity assessment using an automated tool—Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms
title_full_unstemmed Plantar threshold sensitivity assessment using an automated tool—Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms
title_short Plantar threshold sensitivity assessment using an automated tool—Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms
title_sort plantar threshold sensitivity assessment using an automated tool—clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328367/
https://www.ncbi.nlm.nih.gov/pubmed/37418442
http://dx.doi.org/10.1371/journal.pone.0286559
work_keys_str_mv AT castellanovitalekyle plantarthresholdsensitivityassessmentusinganautomatedtoolclinicalassessmentcomparisonbetweenacontrolpopulationwithouttype2diabetesmellitusandpopulationswithtype2diabetesmellituswithandwithoutneuropathysymptoms
AT commanderjon plantarthresholdsensitivityassessmentusinganautomatedtoolclinicalassessmentcomparisonbetweenacontrolpopulationwithouttype2diabetesmellitusandpopulationswithtype2diabetesmellituswithandwithoutneuropathysymptoms
AT burchthomas plantarthresholdsensitivityassessmentusinganautomatedtoolclinicalassessmentcomparisonbetweenacontrolpopulationwithouttype2diabetesmellitusandpopulationswithtype2diabetesmellituswithandwithoutneuropathysymptoms
AT burchhayden plantarthresholdsensitivityassessmentusinganautomatedtoolclinicalassessmentcomparisonbetweenacontrolpopulationwithouttype2diabetesmellitusandpopulationswithtype2diabetesmellituswithandwithoutneuropathysymptoms
AT remyjessica plantarthresholdsensitivityassessmentusinganautomatedtoolclinicalassessmentcomparisonbetweenacontrolpopulationwithouttype2diabetesmellitusandpopulationswithtype2diabetesmellituswithandwithoutneuropathysymptoms
AT harmanbenjamin plantarthresholdsensitivityassessmentusinganautomatedtoolclinicalassessmentcomparisonbetweenacontrolpopulationwithouttype2diabetesmellitusandpopulationswithtype2diabetesmellituswithandwithoutneuropathysymptoms
AT zabalamichaele plantarthresholdsensitivityassessmentusinganautomatedtoolclinicalassessmentcomparisonbetweenacontrolpopulationwithouttype2diabetesmellitusandpopulationswithtype2diabetesmellituswithandwithoutneuropathysymptoms